Research programme: atopic dermatitis/psoriasis therapeutic - BioibericaAlternative Names: Aquasorb
Latest Information Update: 28 Jul 2016
At a glance
- Originator Bioiberica
- Class Glycosaminoglycans; Lipids
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Atopic dermatitis; Psoriasis
Most Recent Events
- 28 Jul 2016 Investigation in Psoriasis in Spain (Topical)
- 28 Jul 2016 Investigation in Atopic dermatitis in Spain (Topical)